GO:0004996 thyroid-stimulating hormone receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004996 describes the molecular function of combining with thyroid-stimulating hormone (TSH) to initiate a change in cell activity, canonically mediated by the TSH receptor (TSHR).
• TSHR is a G-protein-coupled receptor that activates Gs/cAMP and Gq/phospholipase C signaling upon hormone or autoantibody binding.
• TSHR signaling is critical in thyroid physiology and has been implicated in skeletal muscle stem cell regeneration in muscular dystrophy models.
• TSHR autoantibodies are central to Graves' disease and thyroid eye disease, making the receptor a key clinical biomarker and therapeutic target.
• Small-molecule modulators and monoclonal antibodies targeting TSHR are under active development for thyroid-related disorders.
• TSHR glycosylation and post-translational modifications influence receptor trafficking, ligand binding, and signaling output.
Description
Thyroid-stimulating hormone receptor activity (GO:0004996) is a molecular function defined as combining with thyroid-stimulating hormone to initiate a change in cell activity. This activity is canonically executed by the TSH receptor (TSHR), a member of the glycoprotein hormone receptor subfamily of G-protein-coupled receptors. TSHR is best known for its role in thyroid follicular cells, where it transduces signals from TSH to regulate thyroid hormone synthesis, secretion, and growth. The receptor is also expressed in extrathyroidal tissues, including skeletal muscle, where its signaling has been shown to restore stem cell regeneration in rats with muscular dystrophy. Because TSHR sits at the interface of endocrine regulation and autoimmunity, its activity is a major focus in thyroid disease research, including Graves' disease and thyroid eye disease. Understanding the molecular details of GO:0004996 is therefore essential for both basic endocrinology and translational medicine.
thyroid-stimulating hormone receptor activity At A Glance
| GO ID | GO:0004996 |
|---|---|
| GO term | thyroid-stimulating hormone receptor activity |
| Ontology | molecular_function |
| Synonym | thyroid stimulating hormone receptor activity; thyrotropin receptor; TSH receptor activity |
| Major function | Binding TSH to initiate intracellular signaling changes |
| Primary receptor | TSHR (thyroid-stimulating hormone receptor) |
| Signaling pathways | Gs/cAMP and Gq/phospholipase C |
| Clinical relevance | Graves' disease, thyroid eye disease, thyroid cancer |
What Is GO:0004996?
In simple terms, GO:0004996 is the activity of a receptor that binds thyroid-stimulating hormone (TSH) and, upon binding, triggers a change inside the cell. The official definition is: combining with thyroid-stimulating hormone to initiate a change in cell activity. This activity is primarily associated with the TSH receptor (TSHR), a cell-surface receptor that couples hormone binding to intracellular signaling cascades.
Why Is thyroid-stimulating hormone receptor activity Important in Cell Biology?
GO:0004996 is important because it defines the first molecular step in TSH action, a process that controls thyroid hormone production and systemic metabolism. Dysregulation of this activity by autoantibodies or mutations leads to thyroid disease, and its modulation is a therapeutic goal for small molecules and biologics. Moreover, TSHR signaling has been linked to tissue regeneration beyond the thyroid, expanding its biological significance.
• Controls thyroid hormone synthesis and secretion via Gs/cAMP signaling.
• Target of autoantibodies in Graves' disease and thyroid eye disease.
• Expressed in extrathyroidal tissues, including skeletal muscle, where it promotes regeneration.
• Subject of small-molecule modulator development for thyroid disorders.
• Used as a biomarker for thyroid autoimmunity through TRAb immunoassays.
• Glycosylation of TSHR affects its function and is a research focus.
• Monoclonal antibodies against TSHR are tools for studying receptor activation.
• Orthogonal screening assays in human thyroid cells help identify modulators.
What Happens During thyroid-stimulating hormone receptor activity?
Hormone binding and receptor activation
In simple terms: TSH binds to the receptor on the cell surface, like a key in a lock.
TSH binds to the extracellular domain of TSHR, inducing conformational changes that activate the receptor. Structural studies have revealed how hormone and antibody binding stabilize active states of the receptor.
G-protein coupling and second messenger generation
In simple terms: The activated receptor turns on G proteins inside the cell, which make messenger molecules.
Activated TSHR couples primarily to Gs, stimulating adenylyl cyclase and increasing cAMP. It can also couple to Gq, activating phospholipase C and generating inositol trisphosphate and diacylglycerol.
Downstream signaling and cellular responses
In simple terms: The messengers trigger changes in gene expression and cell behavior.
Elevated cAMP activates protein kinase A, which phosphorylates targets that regulate thyroid cell proliferation, differentiation, and hormone synthesis. In skeletal muscle stem cells, TSHR signaling restores regeneration in muscular dystrophy models.
Receptor regulation and desensitization
In simple terms: The cell can turn down the receptor's response after prolonged stimulation.
TSHR undergoes phosphorylation, internalization, and desensitization following sustained activation. Glycosylation of the receptor influences its trafficking and signaling capacity.
Key Genes Involved in GO:0004996 thyroid-stimulating hormone receptor activity
The following genes and proteins are directly involved in thyroid-stimulating hormone receptor activity and its signaling network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSHR | Binds TSH and initiates signaling | Primary receptor for GO:0004996; target in thyroid disease |
| TSHB | Beta subunit of TSH hormone | Ligand for TSHR; regulates receptor activation |
| CGA | Alpha subunit of TSH | Forms functional TSH heterodimer with TSHB |
| GNAS | Gs alpha subunit | Couples TSHR to adenylyl cyclase |
| ADCY | Adenylyl cyclase | Produces cAMP downstream of TSHR |
| PRKACA | cAMP-dependent protein kinase A | Mediates phosphorylation events downstream of TSHR |
| PLCB | Phospholipase C beta | Mediates Gq signaling from TSHR |
| IGF1R | Insulin-like growth factor 1 receptor | Crosstalk with TSHR in thyroid eye disease |
| TSHR autoantibodies | Stimulate or block TSHR | Biomarkers and pathogenic factors in Graves' disease |
| GNAQ | Gq alpha subunit | Couples TSHR to phospholipase C |
| ARRB | Beta-arrestin | Regulates TSHR desensitization and internalization |
| PKA regulatory subunits | Modulate PKA activity | Fine-tune TSHR signaling output |
| TSHR glycosylation enzymes | Modify TSHR post-translationally | Affect receptor function and trafficking |
| TSHR monoclonal antibodies | Bind and modulate TSHR | Research tools and therapeutic candidates |
How Is thyroid-stimulating hormone receptor activity Regulated?
TSHR activity is regulated at multiple levels. Hormone binding is the primary trigger, but receptor glycosylation affects ligand binding and trafficking. Autoantibodies can stimulate or block the receptor, as seen in Graves' disease. Small-molecule modulators can allosterically regulate TSHR signaling. Additionally, receptor desensitization and internalization via beta-arrestin provide negative feedback.
thyroid-stimulating hormone receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSHR | Graves' disease | Knock-in mouse with human TSHR autoantibody epitopes |
| TSHR | Thyroid eye disease | Orbital fibroblast cultures with TSHR overexpression |
| TSHR | Muscular dystrophy | Rat model with TSHR agonist treatment |
| TSHR | Thyroid cancer | TSHR knockout thyroid cell lines |
| TSHR | Congenital hypothyroidism | TSHR point-mutation knock-in mice |
Graves' disease and thyroid autoimmunity
In Graves' disease, autoantibodies bind and activate TSHR, mimicking TSH and causing hyperthyroidism. Detection of TSHR antibodies (TRAb) is a key diagnostic tool, and immunoassays for TRAb are widely used. The receptor is also a target for therapeutic antibodies and small molecules.
Thyroid eye disease (Graves' ophthalmopathy)
TSHR is expressed in orbital fibroblasts and is implicated in thyroid eye disease. TSHR antibodies and IGF1R crosstalk contribute to inflammation and tissue remodeling. Targeting TSHR signaling is a therapeutic strategy for this condition.
Muscular dystrophy and muscle regeneration
TSHR signaling restores skeletal muscle stem cell regeneration in rats with muscular dystrophy, suggesting a role beyond the thyroid. This opens potential therapeutic avenues for muscle degenerative diseases.
From thyroid-stimulating hormone receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TSHR signaling drive thyroid cell proliferation? | TSHR knockout thyroid cell line |
| How do TSHR mutations affect ligand binding? | Point-mutation knock-in of TSHR |
| Can TSHR activation restore muscle regeneration? | TSHR agonist in dystrophic rat model |
| What is the role of TSHR glycosylation? | Knock-in of glycosylation-site mutants |
| How do autoantibodies activate TSHR? | Monoclonal antibody treatment in TSHR-expressing cells |
| Can small molecules modulate TSHR? | Overexpression of TSHR in HEK293 cells for screening |
How to Study the thyroid-stimulating hormone receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| cAMP assay | Intracellular cAMP levels | TSHR activation screening |
| TRAb immunoassay | TSHR autoantibody levels | Clinical diagnosis of Graves' disease |
| Cryo-EM | Receptor structure | Mechanism of hormone/antibody activation |
| Mass spectrometry | Glycosylation profile | TSHR post-translational modification studies |
| Monoclonal antibody binding | Receptor epitope engagement | Receptor activation studies |
| Small-molecule screening | Modulator activity | Drug discovery for TSHR |
| Orthogonal screening | Functional modulation in thyroid cells | Identifying TSHR modulators |
cAMP assays
Measuring cAMP levels is a standard method to assess TSHR activation. Orthogonal screening assays in human thyroid cells have been developed to identify modulators.
Antibody-based detection
TRAb immunoassays are used clinically to detect TSHR autoantibodies and evaluate analytical performance. Monoclonal antibodies against TSHR are used in research.
Structural biology
Cryo-EM and X-ray crystallography have revealed how TSH and antibodies activate TSHR, providing mechanistic insights.
Glycosylation analysis
Mass spectrometry and lectin binding assays assess TSHR glycosylation patterns and their impact on function.
How CRISPR Can Be Used to Study GO:0004996 thyroid-stimulating hormone receptor activity
Knockout
CRISPR knockout of TSHR can abolish TSH signaling, creating a model to study loss of function in thyroid cells and extrathyroidal tissues. This is useful for validating TSHR as a therapeutic target.
Point Mutation
Introducing point mutations in TSHR via CRISPR can mimic naturally occurring variants that alter ligand binding or signaling, helping to dissect structure-function relationships.
Knock-in
Knock-in of tagged or humanized TSHR allows tracking receptor localization and studying autoantibody interactions in vivo.
Overexpression
Overexpressing TSHR in cell lines such as HEK293 enables high-throughput screening for small-molecule modulators and antibody characterization.
How EDITGENE Supports thyroid-stimulating hormone receptor activity Research
Researchers studying thyroid-stimulating hormone receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, autoimmunity, or tissue regeneration. EDITGENE provides CRISPR-based cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for thyroid-stimulating hormone receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TSHR Knockout HEK293 Cell Line | EDJ-KQ1771 | Human | 7253 | Details Get a Quote |
| PAX8 Knockout HEK293 Cell Line | EDJ-KQ5430 | Human | 7849 | Details Get a Quote |
| PAX8 Knockout HCT 116 Cell Line | EDJ-KQ29908 | Human | 7849 | Details Get a Quote |
| TSHR Knockout HeLa Cell Line | EDJ-KQ54698 | Human | 7253 | Details Get a Quote |
| PAX8 Knockout HeLa Cell Line | EDJ-KQ54800 | Human | 7849 | Details Get a Quote |
| TSHR Knockout A-549 Cell Line | EDJ-KQ63185 | Human | 7253 | Details Get a Quote |
| PAX8 Knockout A-549 Cell Line | EDJ-KQ63292 | Human | 7849 | Details Get a Quote |
| TSHR Knockout HCT 116 Cell Line | EDJ-KQ71657 | Human | 7253 | Details Get a Quote |
| TSHR Knockout MOLP-8 Cell Line | EDC07700 | Human | 7253 | Details Get a Quote |
| TSHR Overexpression HEK293 Stable Cell Line | EDJ-GQ117 | Human | 7253 | Details Get a Quote |
Frequently Asked Questions About thyroid-stimulating hormone receptor activity
What is thyroid-stimulating hormone receptor activity?
It is the molecular function defined by GO:0004996, where a receptor binds TSH to initiate a change in cell activity, primarily mediated by TSHR.
What genes are involved in thyroid-stimulating hormone receptor activity?
Key genes include TSHR, TSHB, CGA, GNAS, and ADCY, which together mediate TSH binding and downstream signaling.
What diseases are associated with TSHR activity?
Graves' disease, thyroid eye disease, and congenital hypothyroidism are linked to altered TSHR activity.
How is TSHR activity measured?
cAMP assays, TRAb immunoassays, and structural methods are commonly used.
What is the role of TSHR in muscle regeneration?
TSHR signaling restores skeletal muscle stem cell regeneration in dystrophic rats.
Can TSHR be targeted by drugs?
Yes, small-molecule modulators and monoclonal antibodies are being developed.
What is the difference between TSHR and TSH?
TSH is the hormone ligand; TSHR is the receptor that binds it and signals.
How does glycosylation affect TSHR?
Glycosylation influences receptor trafficking, ligand binding, and signaling.
What are TRAb immunoassays?
They detect TSHR autoantibodies in blood and are used to diagnose Graves' disease.
What model systems are used to study TSHR?
Cell lines, knockout mice, and dystrophic rat models are commonly used.
Conclusion
GO:0004996 thyroid-stimulating hormone receptor activity is a central molecular function in endocrine biology, with broad implications for thyroid disease, autoimmunity, and tissue regeneration. Understanding its mechanism, regulation, and disease links provides a foundation for therapeutic development. CRISPR-based models and screening approaches are powerful tools to dissect this activity further.
References
- 1. Taglietti V et al.. 2023. Thyroid-stimulating hormone receptor signaling restores skeletal muscle stem cell regeneration in rats with muscular dystrophy.. Sci Transl Med 15(685):eadd5275 PMID: 36857434
- 2. Klee AN et al.. 2023. Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies.. Monoclon Antib Immunodiagn Immunother 42(3):109-114 PMID: 37343169
- 3. Korta P et al.. 2019. Glycosylation of thyroid-stimulating hormone receptor.. Endokrynol Pol 70(1):86-100 PMID: 30843179
- 4. Duan J et al.. 2022. Hormone- and antibody-mediated activation of the thyrotropin receptor.. Nature 609(7928):854-859 PMID: 35940204
- 5. Zhang Y et al.. 2024. Targeting Thyroid-Stimulating Hormone Receptor: A Perspective on Small-Molecule Modulators and Their Therapeutic Potential.. J Med Chem 67(18):16018-16034 PMID: 39269788
- 6. Foley B et al.. 2025. Orthogonal screening for thyroid stimulating hormone receptor modulators in human thyroid assays.. Toxicol Sci 207(2):415-434 PMID: 40690393
- 7. Higgins V et al.. 2020. Analytical performance evaluation of thyroid-stimulating hormone receptor antibody (TRAb) immunoassays.. Clin Biochem 86:56-60 PMID: 32858059
- 8. Diana T et al.. 2018. Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease-Methodology and Clinical Applications.. Ophthalmic Plast Reconstr Surg 34(4S Suppl 1):S13-S19 PMID: 29771755
